Previous 10 | Next 10 |
home / stock / polxf / polxf news
Fast Retailing Co. Ltd. ADR (FRCOY) is expected to report for Q4 2023 Walgreens Boots Alliance Inc. (WBA) is expected to report $0.68 for Q4 2023 Rite Aid Corporation (RAD) is expected to report $-1.35 for Q2 2024 Greystone Logistics Inc (GLGI) is expected to report for Q2 2024 Se...
Uni Charm Corporation ADR (UNICY) is expected to report for Q2 2023 Clarus Therapeutics Hldgs (CRXTQ) is expected to report for quarter end 2023-06-30 Bed Bath & Beyond Inc. (BBBYQ) is expected to report for Q2 2024 CalAmp Corp. (CAMP) is expected to report $-0.04 for Q2 2024 ...
Novonix Limited (NVNXF) is expected to report for quarter end 2023-06-30 LifeWorks Inc (MSIXF) is expected to report for quarter end 2023-06-30 Arrival (ARVL) is expected to report for quarter end 2023-06-30 Treasure Global Inc. (TGL) is expected to report $-0.16 for Q4 2023 Manch...
Polydex Pharmaceuticals Inc (POLXF) is expected to report for Q2 2024
TORONTO, July 18, 2023 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company” or “Polydex”) held a Special Meeting on July 14, 2023 relating to a Plan of Arrangement involving Polydex Pharmaceuticals Limited, Biospectra International I...
2023-06-15 12:17:15 ET Polydex Pharmaceuticals press release ( OTCPK:POLXF ): Q1 GAAP EPS of -$0.04. Revenue of $1.49M (+28.4% Y/Y). For further details see: Polydex Pharmaceuticals GAAP EPS of -$0.04, revenue of $1.49M
2023-05-01 17:01:55 ET Polydex Pharmaceuticals press release ( OTCPK:POLXF ): FY GAAP EPS of -$0.22. Revenue of $4.4M (+4.0% Y/Y). For further details see: Polydex Pharmaceuticals GAAP EPS of -$0.22, revenue of $4.4M
TORONTO, April 27, 2023 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company” or “Polydex”) announced today that it has entered into a Plan of Arrangement agreement (the “Arrangement Agreement”) whereby BioSpectra, Inc. ...
This pharmaceutical company specializes in bulk %Pharmaceuticals for the %Veterinary industry. The veterinary pharmaceutical market is estimated at USD 29.4 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.3 percent. Toronto-based %PolydexPh...
Polydex Pharmaceuticals press release ( OTCPK:POLXF ): Q2 GAAP EPS of -$0.09. Revenue of $1.09M (-18.7% Y/Y). For further details see: Polydex Pharmaceuticals GAAP EPS of -$0.09, revenue of $1.09M
News, Short Squeeze, Breakout and More Instantly...
IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2023-10-31 Deluxe Corporation (DLX) is expected to report $0.62 for Q4 2023 SkyWest Inc. (SKYW) is expected to report $0.11 for Q4 2023 1-800-FLOWERS.COM Inc. (FLWS) is expected to report $1.22 for Q2 2024 Brook...
Koss Corporation (KOSS) is expected to report for Q2 2024 Waterstone Financial Inc. (WSBF) is expected to report for Q4 2023 Silver Bull Resources Inc (SVBL) is expected to report for quarter end 2023-10-31 Xcel Energy Inc. (XEL) is expected to report $0.85 for Q4 2023 Sodexo ADR ...
Polydex Pharmaceuticals Inc (POLXF) is expected to report for quarter end 2023-10-31 RF Industries Ltd. (RFIL) is expected to report $-0.06 for Q4 2023 Northern Trust Corporation (NTRS) is expected to report $1.33 for Q4 2023 KeyCorp (KEY) is expected to report $0.22 for Q4 2023 S...